Antibody drug conjugates

This biopharma company has marked out a path to profitability by licensing its drug expertise and antibody platforms to partners such as Pfizer.

HBM gets health boost from drug licensing deals

The biopharma company has marked out a path to profitability by licensing its drug expertise and antibody platforms to partners such as Pfizer Key Takeaways: Nona Biosciences, a subsidiary of…
2142.HK

Recent Articles

RELATED ARTICLES

  1. Everest's nefecon included on national drug list
    Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
    1952.HK
  2. Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
    1952.HK
  3. Cancer drug maker Genfleet joins Hong Kong IPO influx
  4. A blockbuster cancer drug? TYK’s claims go under the microscope
    2410.HK
  5. As Covid drug cash dwindles, Vigonvita targets new remedies
  6. Cloudbreak Pharma sets sights on Hong Kong IPO after license deal
  7. Innovent ditches low-value stake sale after investor outcry
    1801.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva